Glazer Capital LLC’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Glazer Capital LLC’s Portfolio IDIX Stock Details IDIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-981,058	Closed	-$23.6M	–	89
2014 Q2	$23.6M	Buy	+981,058	New	+$10.2M	9.35%	2

Glazer Capital LLC's IDIX Position: Q3 2014 in Review

Glazer Capital LLC sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 981,058 shares — an estimated $23.6M sold.

Glazer Capital LLC first reported a position in IDIX in Q2 2014 and held it in 1 quarter. The position peaked at $23.6M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

Glazer Capital LLC reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
Glazer Capital LLC sold 981,058 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $23.6M.
Glazer Capital LLC first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2014 and held it in 1 quarter.
Glazer Capital LLC's IDENIX PHARMACEUTICALS INC position peaked at $23.6M in Q2 2014.
0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Glazer Capital LLC's 13F filing for Q3 2014, filed 14 Nov 2014.